| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 366-6C-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF366-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB366-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3661-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35002-1mg | |||
| Carrier-Free | NBP2-35002-100ug | |||
| Carrier-Free | NBP2-35002-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35179-20ug | |||
| Carrier-Free | NBP2-35179-1mg | |||
| Carrier-Free | NBP2-35179-100ug | |||
| Carrier-Free | NBP2-35179-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 966-6C-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 7949-6C-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12103-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12104-0.025mg | |||
![N/A CCL21/6Ckine [Biotin]](http://images.novusbio.com/fullsize2/DATA_CCL21_DY366_ELISA_1970.jpg "N/A CCL21/6Ckine [Biotin]")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining in human lymph node and cerebral cortex tissues using anti-CCL21 antibody. Corresponding CCL21 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining in human lymph node and cerebral cortex tissues using anti-CCL21 antibody. Corresponding CCL21 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human spleen shows moderate cytoplasmic positivity in cells in red pulp.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0010.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0004.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0005.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human cerebral cortex shows no cytoplasmic positivity in neuronal cells as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0008.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human placenta shows no cytoplasmic positivity in trophoblastic cells as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0009.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human tonsil shows moderate to strong cytoplasmic positivity in germinal center cells.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0011.jpg)
![SDS-Page: Human CCL21/6Ckine Protein [NBP2-35002]](http://images.novusbio.com/fullsize/Human-CCL21-6Ckine-Protein-SDS-Page-NBP2-35002-img0001.jpg "SDS-Page: Human CCL21/6Ckine Protein [NBP2-35002]")
![SDS-Page: Mouse CCL21/6Ckine Protein [NBP2-35179]](http://images.novusbio.com/fullsize/Mouse-CCL21-6Ckine-Protein-SDS-Page-NBP2-35179-img0001.jpg "SDS-Page: Mouse CCL21/6Ckine Protein [NBP2-35179]")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-MM0146-2H26-Immunohistochemistry-Paraffin-NBP2-12103-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-RM0174-10K10-Immunohistochemistry-Paraffin-NBP2-12104-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104")